콘텐츠로 건너뛰기
주식/증권 ➡️ 중립

Bristol Myers Squibb Stock Soars on Report of $400 Billion Merger Talks With AstraZeneca

Yahoo Finance 2026/08/03 09:54:00 3회
요약

The merger would be one of the biggest pharma deals ever. AstraZeneca’s market capitalization stood at $264 billion as of Friday’s close, while Bristol Myers Squibb had a total valuation of $133 billion.

원문 기사 보기
관련 뉴스
Vistra targets $6.8B-$7.6B 2026 adjusted EBITDA while committing up to $1B to Helix partnership
2026/08/07
Post anticipates fiscal 2027 adjusted EBITDA near $1.48B as it shifts capital allocation toward debt reduction
2026/08/07
PPL projects 6% to 8% annual EPS growth through at least 2029 as signed Pennsylvania data center agreements reach 32 GW
2026/08/07
Granite Ridge signals $65 oil underpinning for 10% 2027 free cash flow yield while resetting LOE guidance to $8.25-$9.25 per BOE
2026/08/07
뉴스 목록으로